INGN 201 (trade name: Advexin)
Treatment of head and neck cancer
Date designated: 1/27/2003
Introgen Therapeutics, Inc.
2250 Holcombe Blvd.
Houston, TX 77030
lactoferrin alpha
Treatment of graft versus host disease (GVHD)
Date designated: 8/20/2003
Also: for the prevention of GVHD
Date designated: 8/20/2003
Agennix, Inc.
8 Greenway Plaza, Suite 910
Houston, TX 77046
liposomal p-ethoxy growth receptor bound protein-2
Treatment of chronic myelogenous leukemia (CML)
Date designated: 12/5/2003
Interpath Pharmaceuticals, Inc.
2615 Hollymist
Houston, TX 77084
mafosfamide
Treatment of meningitis caused by cancer
Date designated: 1/21/2003
Baxter Oncology GmbH
Daimlerstrasse 40
60314 Frankfurt/Main
MaxAdFVIII
Treatment of classic hemophilia (hemophilia A)
Date designated: 3/3/2003
GenStar Therapeutics Corporation
10865 Altman Row, Suite 200
San Diego, CA 92121-1113
monarsen
Treatment of myasthenia gravis
Date designated: ?
Medica Venture Partners
11 Hamanofim St.
Ackerstein Towers
Building B, 10th Floor
Herzlia 46725, Israel
motexafin gadolinium (trade name: Xcytrin)
Treatment of metastatic brain tumors
Date designated: 1/27/2003
Pharmacyclics, Inc.
999 East Arques Avenue
Sunnyvale, CA 94085-4521
Rexin-G retroviral (trade name: Rexin-G)
Treatment of pancreatic cancer
Date designated: 8/15/2003
Epeius Biotechnologies Corporation
345 Pioneer Drive, 1803W
Glendale, CA 91203
myristoylated recombinant SCR1-3 of human complement receptor type I
Prevention of delayed graft function in solid organ transplant
Date designated: 5/21/2003
Adprotech, Ltd.
Chesterford Research Park
Little Chesterford
Near Cambridge
Essex, UK CB10 1XL
N-acetyl-sarcosyl-glycyl-L-valyl-D-alloisoleucyl-L-threonyl-L-norvalyl-L-isoleucyl-L-arginyl-L-prolylethylaminde acetate
Treatment of soft tissue sarcoma
Date designated: 12/9/2003
Abbott Laboratories
Pharmaceutical Products Division
200 Abbott Park Road
Abbott Park, IL 60064
niprisan (trade name: Hemoxin)
Treatment of sickle cell disease
Date designated: 8/15/2003
Xechem International, Inc.
New Brunswick Technology Center
100 Jersey Avenue, Building B, Suite 310
New Brunswick, NJ 08901
polyinosinic-polycytidilic acid (trade name: Poly-ICLC)
Treatment of flavivirus infections including West Nile, Japanese encephalitis, dengue, St. Louis encephalitis, yellow feer, Murray valley, and Banzai viruses
Date designated: 3/3/2003
Ribopharm, Inc.
3203 Cleveland Ave., NW
Washington, DC 20008-3450
protaxel
Treatment of ovarian cancer
Date designated: 5/21/2003
Biophysica, Inc.
3333 North Torrey Pines Court, Suite 100
La Jolla, CA 92037
recombinant adeno-associated virus alpha 1-antitrypsin vector (trade name: rAAV-AAT)
Treatment of alpha 1-antitrypsin deficiency
Date designated: 1/27/2003
Applied Genetic Technologies Corp.
12085 Research Drive, Suite 110
Alachua, FL 32615
recombinant human neutrophil inhibitor (hNE) (product name: DX-890)
Treatment of cystic fibrosis
Date designated: 12/9/2003
Dyax Corporation
300 Technology Square
Cambridge, MA 02139
recombinant inhibitor of human plasma kallikrein (product name: DX-88)
Treatment of angioedema
Date designated: 2/4/2003
Dyax Corporation
300 Technology Square
Cambridge, MA 02139
recombinant T-cell receptor (product name: VGI303)
Treatment of multiple sclerosis
Date designated: 5/2/2003
Virogenomics, Inc.
9020 SW Washington Square Road, Suite 380
Tigard, OR 97223-4332
repertaxin
Prevention of delayed graft function in solid organ transplant
Date designated: 1/27/2003
Dompe S.p.A.
Via Campo de Pile
67100 - L'Aquila - Italia
repository corticotropin or adrenocorticotropic hormone (trade name: H.P. Acthar Gel)
Treatment of infantile spasms (seizures)
Date designated: 5/21/2003
Questcor Pharmaceuticals, Inc.
3260 Whipple Road
Union City, CA 94587-1217
resiniferatoxin
Treatment of intractable (unable to be relieved) pain at end-stage disease
Date designated: 5/13/2003
Andrew J. Mannes, MD
Bldg 10/Rm 2N236
DASS/PPCS/NIDCR/NIH
10 Convent Drive
Bethesda, MD 20892
rhlGF-l/rhlGFBP-3 (trade name: SomatoKine)
Treatment of insulin resistance syndromes such as Type A, Type B, and Rabson-Mendenhall syndromes
Date designated: 12/9/2003
Insmed Inc.
4851 Lake Brooke Drive
Glen Allen, VA 23060
rhuMAb VEGF (bevacizumab) (trade name: Avastin)
Treatment of renal cell carcinoma
Date designated: 11/6/2003
Genentech, Inc.
1 DNA Way
South San Francisco, CA 94080-4990
SC-1 monoclonal antibody
Treatment of stomach tumors
Date designated: 11/12/2003
H3 Pharma, Inc.
666 Sherbrooke Street West, Suite 1400
Montreal, Quebec
SGN-30 (anti CD30 mAb)
Treatment of Hodgkin's disease
Date designated: 7/18/2003
Seattle Genetics, Inc.
21823 30th Drive, Southeast
Bothell, WA 98021
siplizumab
Treatment of T-cell lymphomas
Date designated: 7/15/2003
MedImmune Oncology, Inc.
35 W. Watkins Mill Road
Gaithersburg, MD 20878
sodium dichloroacetate
Antidote for systemic monochloroacetic acid poisoning
Date designated: 7/3/2003
EBD Group
6120 Paseo del Norte, Suite J2
Carlsbad, CA 92009
